Sudarshan Chemical Industries Limited — Important, 26-07-2025: Disclosure of material issue

Sudarshan Chemical Industries has announced its financial results for the quarter and year ended March 31, 2025.

**Financial Snapshot (Consolidated, YoY):**

Revenue for Q4 FY25 surged by 76% to ₹1,349.44 Cr. While reported profit for the quarter was ₹10.56 Cr (down from ₹78.02 Cr), this was primarily impacted by ₹61.64 Cr in one-time exceptional costs related to the Heubach acquisition. However, total comprehensive income saw an astounding jump to ₹1,295.29 Cr, driven by a massive **₹1,243.85 Cr "bargain purchase gain"** from the Heubach deal, reflecting the acquisition of net assets for less than their fair value. Total assets more than quadrupled to ₹9,730.71 Cr, reflecting the scale of the acquisition.

**The Big Story: Heubach Acquisition**

Sudarshan Europe B.V., a wholly-owned subsidiary, completed the acquisition of the global pigment business of Heubach Group on March 3, 2025, for approximately €151.9 million (₹1,389.90 Cr). This strategic move significantly expands the company's global footprint in the Pigments segment. The acquisition was funded through a combination of external funds raised by the parent company and borrowings by SEBV.

**The Key Issue:**

A significant issue has emerged concerning the newly acquired subsidiary, Heubach Colorants India Limited (HCIL). Back in 2019, HCIL saw certain assets (worth ₹25.81 Cr) transferred to a then-related party without proper board approval.

* **Possible Impact:** This could lead to a potential adverse financial impact on HCIL and, by extension, the consolidated financials, though the final resolution and its effects are still pending.

* **Company's Response/Mitigation:** HCIL has engaged independent agencies for a fact-finding exercise, is negotiating to recover assets, and is evaluating various legal options to address the matter.

**Other Important Updates:**

* **Fundraising:** The company successfully raised approximately ₹1,000 Cr via a combination of warrants issued to a promoter (₹24.98 Cr), a preferential allotment (₹195.00 Cr), and a Qualified Institutional Placement (QIP) (₹799.99 Cr). These funds were primarily utilized for the Heubach acquisition and general corporate purposes.

* **Open Offer:** An amount of ₹361.50 Cr has been set aside in an escrow account for an upcoming open offer for 26% of Heubach Colorants India Ltd, pending SEBI approval.

* **Corporate Guarantee:** A corporate guarantee up to EURO 25 Million has been approved for subsidiaries to manage foreign exchange exposures, which will be disclosed as a contingent liability.

* **Dividend:** The Board has proposed a dividend of ₹4.5 per share (225%) for FY24-25, awaiting shareholder approval.

* **Leadership:** Mr. Rajesh Balkrishna Rathi has been appointed Chairman of the Board, in addition to his role as Managing Director.

**Analyst's Take:** Sudarshan Chemical is undergoing a major transformation with the Heubach acquisition, positioning itself for substantial long-term growth in the pigments sector. The "bargain purchase gain" is a significant accounting positive. While immediate quarter profits were impacted by one-off acquisition costs, the underlying strategic benefits and balance sheet expansion are clear. Investors should keep a close watch on the resolution of the legacy asset transfer issue at HCIL, which represents a potential, though currently undefined, risk.